Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients
Clinical trial NCT02588859 · COMPLETED
Trial details
- NCT number
- NCT02588859
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-10-30
- Primary completion
- 2016-12-26
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.